CompletedInterventionalPhase 4Updated Feb 21, 2019
Impact of Balanced Slat Colloid HES 130/0.42 on Coagulation Profiles in Patients Undergoing Spinal Cord Tumor Surgery | NCT01921595 | Trialant
TerminatedInterventionalNot ApplicableUpdated Mar 29, 2019
Impact of Balanced Slat Colloid HES 130/0.42 on Coagulation Profiles in Patients Undergoing Spinal Cord Tumor Surgery
ClinicalTrials.gov ID
NCT01921595
Lead Sponsor
Yonsei UniversityOTHER
Overall Status
Terminated
Study Type
Interventional
Phase
Not Applicable
Enrollment
6Actual
Last Update Posted
Mar 29, 2019Actual
Start Date
Aug 2013
Primary Completion Date
Jan 31, 2015Actual
Completion Date
Jan 31, 2015Actual
Brief Summary
The purpose of study is to compare the effect of coagulation profile in patients receiving intraoperative balanced salt colloid undergoing spinal cord tumor surgery.
Coagulation
Valanced salt colloid
Valanced salt crystalloid group
Ages Eligible for Study
Adult (18-64)Older Adult (65+)
Sexes Eligible for Study
All
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
adult patients over the age of 20 scheduled for spinal tumor removal and fixation
Exclusion Criteria:
1. Renal failure 2. Preexisting congestive heart failure(NYHA III ~ IV) 3. Anemia 4. Coagulopathy 5. Abnormal liver function 6. Anti coagulation/Anti platelet ,edication 7. Foreigner, illiterate 8. Disabled person,
Primary Purpose
Other
Allocation
Randomized
Interventional Model
Parallel Assignment
Masking
None (Open Label)
No central contacts
There are no central contacts for this study.
Department of Anesthesiology and Pain Medicine, Yonsei University College of Medicine